A second meta-analysis included 2632 cases of colorectal cancer or adenoma and 2753 healthy controls [25]; findings of this meta-analysis suggest that adiponectin levels are statistically significantly lower in patients with colorectal cancer or adenoma compared with controls. This evidence concerns the gene ADIPOQ and colorectal cancer.